Ashizawa, Ana Tari
Holt, Jenny
Faust, Kelsey
Liu, Weier
Tiwari, Anjana
Zhang, Nan
Ashizawa, Tetsuo http://orcid.org/0000-0001-7180-2869
Funding for this research was provided by:
University of Florida (UF Opportunity)
Article History
First Online: 9 July 2018
Compliance with Ethical Standards
:
: ATA is an employee and stock holder of Bio-Path Holdings, Inc. TA is Adjunct Professor of Baylor College of Medicine, and receives grants from the NIH (R01 NS083564), the National Ataxia Foundation (NAF), the Myotonic Dystrophy Foundation (MDF), and the Marigold Foundation, and has been supported by Biohaven Pharmaceuticals and Ionis Pharmaceuticals for clinical trials of their drugs, and by Pacific Biosciences for symposium honoraria. TA also serves on the Medical and Research Advisory Board of the NAF, and the Scientific Advisory Board of the MDF. ATA and TA filed a US patent application (Serial # 14/390,584).
: The animal research in this work was approved by the UF Institutional Animal Care and Use Committee (IACUC #201307878).
: This work does not involve human subject research.